Close Menu

NEW YORK – The UK Health and Social Care Secretary announced late on Wednesday a £500 million ($667 million) investment in new SARS-CoV-2 testing technology to increase the country's testing capacity.

The new funding builds on an initiative announced in August by the UK's Department of Health and Social Care (DHSC) to roll out rapid coronavirus tests from DnaNudge and Oxford Nanopore Technologies to hospitals, care homes, and laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.